Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
塞拉地帕治疗可降低原发性胆汁性胆管炎患者的IL-31水平并减轻瘙痒症状。
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000728
Kremer, Andreas E; Mayo, Marlyn J; Hirschfield, Gideon M; Levy, Cynthia; Bowlus, Christopher L; Jones, David E; Johnson, Jeff D; McWherter, Charles A; Choi, Yun-Jung
